Acute hypoxemic respiratory failure (AHRF) is a major complication of COVID-19 pneumonia and parasternal intercostal muscle thickening may be used as a biomarker to assess inspiratory effort. We report the case of a high utilization of parasternal intercostal muscle prior to the introduction of invasive ventilation in a 66-year old male none vaccinated COVID -19 patient admitted in hospital because of AHRF.
Keywords: AHRF, acute hypoxemic respiratory failure; COVID-19; HFNC, high flow nasal cannula; Parasternal intercostal muscle; TFic, parasternal muscle intercostal thickening fraction; Ultrasound.
© 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington.